Sulgan-N ointment 30 g

Sulgan-N Salbe 30 g

Brand: DOETSCH GRETHER AG
Product Code: 2349741
Availability: 700
26.55 USD Price in reward points: 3211
Add to Cart
Add More for Bigger Discounts! Details

Buy 2 and save 8.92 USD / -18%


Description

Sulgan-N is a medicine for the local treatment of hemorrhoids.

Hemorrhoids are varicose veins in the lower rectum and can occur both inside and outside the anus. The condition usually manifests itself through itching, burning, pain and, in severe cases, bright red superficial blood admixtures during bowel movements. This sometimes leads to tears in the anal mucosa (anal fissures), inflammation and eczema in the anal area, and the possibility of infection increases.

Treatment with Sulgan-N eliminates itching and pain, reduces inflammation and thereby relieves the discomfort caused by hemorrhoids.

Sulgan-N preparations are used for internal and external hemorrhoids:

Sulgan-N ointment

External and internal haemorrhoids, anal eczema, superficial tears in the anal skin (anal fissures), slight inflammation and itching in the area of ​​the anus.

Sulgan-N suppositories

Internal hemorrhoids, superficial anal fissures. On the recommendation of a doctor or pharmacist, the suppositories can also be used for mild inflammation and itching in the area of ​​the lower rectum.

Sulgan-N medical wipes

For anal hygiene in hemorrhoids, anal eczema, anal fissures, slight inflammation and itching in the area of ​​the anus.

Swissmedic-approved patient information

Sulgan-N®Doetsch Grether AG

AMZV

What is Sulgan-N and when is it used?

Sulgan-N is a medicine for the local treatment of hemorrhoids.

Hemorrhoids are varicose veins in the lower rectum and can occur both inside and outside the anus. The condition usually manifests itself through itching, burning, pain and, in severe cases, bright red superficial blood admixtures during bowel movements. This sometimes leads to tears in the anal mucosa (anal fissures), inflammation and eczema in the anal area, and the possibility of infection increases.

Treatment with Sulgan-N eliminates itching and pain, reduces inflammation and thereby relieves the discomfort caused by hemorrhoids.

Sulgan-N preparations are used for internal and external hemorrhoids:

Sulgan-N ointment

External and internal haemorrhoids, anal eczema, superficial tears in the anal skin (anal fissures), slight inflammation and itching in the area of ​​the anus.

Sulgan-N suppositories

Internal hemorrhoids, superficial anal fissures. On the recommendation of a doctor or pharmacist, the suppositories can also be used for mild inflammation and itching in the area of ​​the lower rectum.

Sulgan-N medical wipes

For anal hygiene in hemorrhoids, anal eczema, anal fissures, slight inflammation and itching in the area of ​​the anus.

What should be considered?

If you suffer from hemorrhoids, you should avoid spicy foods and choose a diet that leads to loose stools (preferably light, plant-based diet). You should avoid being overweight or reduce existing overweight, avoid sitting for too long and, to reduce the risk of inflammation and infection, pay attention to careful anal hygiene. This allows you to support the effect of Sulgan-N ointment and suppositories.

When must Sulgan-N not be used?

Sulgan-N must not be used in case of hypersensitivity to one of the ingredients (see below: What side effects can Sulgan-N have ?). Furthermore, you must not use the preparations if blood is visible in the stool. Your doctor knows what to do in such cases.

Sulgan-N is only suitable for adults and not for children.

When is caution required when using Sulgan-N?

If used as directed, no special precautions need to be followed.

Inform your doctor, pharmacist or druggist if you suffer from other illnesses, have allergies or are taking other medicines (even those you bought yourself!) or using them externally.

Can Sulgan-N be used during pregnancy or breastfeeding?

Based on previous experience, there is no known risk for the child when used as directed. However, systematic scientific investigations have never been carried out. To be on the safe side, you should avoid taking medicines during pregnancy and breastfeeding or ask your doctor, pharmacist or druggist for advice.

How do you use Sulgan-N?

Before each treatment and after each bowel movement, wash the anal area carefully with lukewarm water and possibly mild soap and a soft cloth or with Sulgan -Clean the N-medicinal wipes carefully. Ordinary soaps cause irritation that delays the healing process.

Adults:

Sulgan-N ointment: Apply a strand of ointment 1 to 2 cm long to the affected areas two to three times a day. In the case of internal hemorrhoids, screw the enclosed cannula onto the tube. Insert the cannula as far as possible into the anus and slowly withdraw the cannula while gently squeezing the tube.

Sulgan-N suppositories: Carefully insert 1 suppository into the anus in the evening in bed. Bedridden patients can insert one suppository two to three times a day.

Sulgan-N medical wipes: Clean the anal area carefully and thoroughly if necessary.

If the symptoms have not disappeared after 1-2 weeks of treatment or have decreased significantly or have even worsened, e.g. if bleeding occurs on or from the anus, you must consult a doctor. The doctor will decide on further treatment.

Repeated treatments may only be carried out after a medically confirmed diagnosis and should not last longer than 2 weeks.

Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Sulgan-N have?

The following side effects can occur when using Sulgan-N:

An occasional burning sensation when using Sulgan-N medical wipes is due to the effect of the active ingredients on an existing skin defect and can be considered a normal reaction. With continued treatment, this side effect will disappear. In rare cases, hypersensitivity reactions can occur, which are noticeable, for example, through itching, burning and/or a skin rash in the area of ​​the anus. In such a case, you must stop the treatment immediately and inform a doctor.

If you notice side effects that are not described here, you should inform your doctor, pharmacist or druggist.

What else needs to be considered?

For hygienic reasons, Sulgan-N ointment should be used up within 14 days after first opening. The medicinal product may only be used up to the date marked “EXP” on the container. Medicines should be kept out of the reach of children and at room temperature (15-25 °C).

Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.

What does Sulgan-N contain?

1 g of ointmentcontains: lidocaine hydrochloride anhydride 20 mg, racemic camphor 10 mg, levomenthol 5 mg.

Excipients: wool wax, propylene glycol; Conserv.: 2,4-dichlorobenzyl alcohol, triclosan and other excipients.

1 suppository contains: lidocaine 4.3 mg, racemic camphor 20 mg, levomenthol 10 mg.

Excipients: propylene glycol; Conserv.: 2,4-dichlorobenzyl alcohol, triclosan and other excipients.

Medical wipes in sachets

1 wipe is soaked with 3.1 g of solution.

1 g solution contains: lidocaine hydrochloride 4.4 mg, racemic camphor 10 mg, levomenthol 3 mg.

Excipients: wool wax, propylene glycol; Conserv.: 2,4-dichlorobenzyl alcohol; Aromatica and other excipients.

Medical wipes in the dispenser

1 wipe is soaked with 1.7 g of solution.

1 g solution contains: lidocaine hydrochloride 4.4 mg, racemic camphor 10 mg, levomenthol 3 mg.

Excipients: wool wax, propylene glycol; Conserv.: 2,4-dichlorobenzyl alcohol; Aromatica and other excipients.

Approval number

48724, 48725, 48726 (Swissmedic).

Where can you get Sulgan-N? What packs are available?

In pharmacies and drugstores without a doctor's prescription.

Ointment: 30 g and 50 g

Suppositories: 10 and 20 pieces

Medication wipes in sachets: 10 sachets

Medical wipes in the dispenser: 25 pieces

Authorization holder

Doetsch Grether AG, 4051 Basel.

This leaflet was last checked by the Medicines Agency (Swissmedic) in June 2017.